The global submucosal lifting agent market is on a trajectory for remarkable growth, with projections indicating a compound ...

Recombinant human hyaluronidase PH20 enabled rapid SC delivery by removing glycosaminoglycan hyaluronan blockage. Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing ...